Two radiotherapy treatments show similar morbidity, cancer control after prostatectomy
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, ...
Cancer
May 20, 2013 |
not rated yet |
0
Hospital surgical volume should be considered when judging value of procedures
The volume of cases performed at an institution each year has a direct effect on the outcome of surgical procedures, and should always be considered when looking at the benefits of a technique, according to a team of researchers ...
Cancer
May 05, 2013 |
not rated yet |
0
GPS-like technology helps diagnose prostate tumors
The lead investigator of a way to obtain images of prostate tumors and accurately diagnose them said Thursday that the new technology is the medical equivalent of a global positioning system for the prostate gland.
Cancer
May 03, 2013 |
5 / 5 (1) |
0
Genetic testing may be used to identify BPH patients with increased risk of prostate cancer
Patients with benign prostatic hyperplasia (BPH) carrying prostate cancer (PCa) a risk alleles are a potential target population for PCa screening and follow-up, according to a study, which was presented yesterday at the ...
Cancer
Mar 19, 2013 |
not rated yet |
0
Novel small molecules used to visualize prostate cancer
Two novel radiolabeled small molecules targeting prostate-specific membrane antigen (PSMA) have excellent potential for further development as diagnostic and therapeutic radiopharmaceuticals, according to research published ...
Cancer
Mar 05, 2013 |
not rated yet |
0
Could duration of prostate cancer hormone therapy be halved?
(HealthDay)—For some men with prostate cancer, hormonal therapy to beat the disease could be safely cut from three years to half that time, a new clinical trial suggests.
Cancer
Feb 13, 2013 |
5 / 5 (1) |
0
|
New genetic test can predict man's risk of developing prostate cancer
Researchers in Japan have created a genetic test that will help doctors diagnose prostate cancer. When given together with testing for prostate specific antigen (PSA), a widely used diagnostic biomarker for ...
Cancer
Feb 08, 2013 |
5 / 5 (3) |
0
|
Researchers find new culprit in castration-resistant prostate cancer
Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They ...
Cancer
Dec 13, 2012 |
not rated yet |
0
|
Advanced imaging pinpoints prostate cancer faster, more accurately
It took Wayne Wentzel 14 years, multiple tissue biopsies and travel to four hospitals across multiple states to identify the underlying source of his rising prostate specific antigen (PSA) level. He finally ...
Cancer
Oct 05, 2012 |
5 / 5 (1) |
1
Hormone-depleting drug shows promise against localized high-risk prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
Cancer
May 16, 2012 |
5 / 5 (1) |
0
Want to avoid ED following prostate cancer surgery? Find an experienced, gentle surgeon
Prostate cancer is the most commonly diagnosed non-skin cancer in the U.S., and radical prostatectomy, the surgical removal of the prostate gland, remains the most popular therapeutic option, accounting for ...
Surgery
May 16, 2012 |
not rated yet |
0
|
New diagnostic tool determines aggressiveness of prostate cancer
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States.
Cancer
Apr 25, 2012 |
not rated yet |
0
|
Component of pizza seasoning herb oregano kills prostate cancer cells
Oregano, the common pizza and pasta seasoning herb, has long been known to possess a variety of beneficial health effects, but a new study by researchers at Long Island University (LIU) indicates that an ingredient of this ...
Cancer
Apr 24, 2012 |
not rated yet |
0
Study examines the relative roles of testosterone and its metabolite, dihydrotestosterone in men
Men receiving testosterone supplementation who also received a drug (dutasteride) commonly used to treat an enlarged prostate gland and which blocks the conversion of testosterone to its potent metabolite DHT did not experience ...
Medical research
Mar 06, 2012 |
not rated yet |
0
Nerve sparing helps most prostate cancer patients to have same orgasms as before surgery
The vast majority of men who have a prostate cancer operation can retain their ability to orgasm if the surgery is carried out without removing the nerves that surround the prostate gland like a hammock, according to a study ...
Surgery
Feb 13, 2012 |
5 / 5 (2) |
0
